🔬 100K+ researchers trust BodyHackGuide — Join r/BodyHackGuide

AdaptogenPreclinical

American Ginseng Dosage Guide: Protocols, Calculator & Safety

Everything you need to know about American Ginseng dosing — protocols, safety, and where to buy.

Dosage Calculator

Calculate exact dosing for American Ginseng.

Dosing Protocols

Beginner

Beginner Protocol (new users, first 2-4 weeks):

Start with 500 mg/day of whole-root Wisconsin Ginseng (or equivalent American ginseng powder) taken once daily with breakfast, for 5-7 days. This lower starting dose allows you to detect any sensitivity (rare mild GI upset, occasional insomnia if dosed late, or hypoglycemia in diabetic patients) without confounding the clinical signal.

After 5-7 days at the starting dose with good tolerance, increase to 1,000 mg/day for the remainder of the first month. This dose is within the clinical range for most indications (cognitive support, general vitality, mild immune support, T2DM adjunct).

For the CVT-E002 / Cold-fX preparation specifically (immune support during respiratory infection season), start at 200 mg once daily for 3-5 days, then increase to 200 mg twice daily as the maintenance dose throughout the winter season.

Expected response timeline:

Acute cognitive and energy effects: within hours to days (Scholey 2010 single-dose data)
Fatigue reduction: 2-4 weeks of chronic dosing
CRF effects: 4-8 weeks (Barton 2013 timeline)
Immune support: prophylactic throughout the infection season
T2DM glucose effects: 8-12 weeks (Vuksan protocol)

Timing: morning dose with breakfast. Unlike Asian ginseng, American ginseng's lower stimulant profile allows for afternoon dosing without insomnia risk in most users — but morning-only dosing remains safer as a default.

Brand recommendations for beginners:

Wisconsin Ginseng Board-certified brands: CW Ginseng, HSU's Ginseng, Burnett Ginseng, Marathon Co. Ginseng. All are Wisconsin-grown, Board-certified, and provide pure single-origin root powder or capsules. This is the evidence-based default for American ginseng.
CVT-E002 / Cold-fX (for immune support): Cold-fX in Canada (over-the-counter), COLD-fX in some US markets, Jamieson Cold-fX. Proprietary polysaccharide-enriched extract with strongest clinical immune evidence.
Life Extension American Ginseng — reliable manufacturer with third-party testing.
NOW American Ginseng — budget-friendly, standardized extract.
Solaray American Ginseng — mid-tier.

Avoid: generic "American ginseng" without Wisconsin Ginseng Board certification or Canadian grower verification; bulk powders without sourcing transparency; products mixing Panax quinquefolius with Panax ginseng without clear labeling.

Standard

Intermediate Protocol (established users, months 2-6):

Standard clinical dose: 1,000-3,000 mg/day of American ginseng whole root powder, taken as once-daily morning dose or split between morning and noon with meals. The Barton 2013 CRF protocol (2,000 mg/day) is the best-documented intermediate dose for fatigue indications. For T2DM adjunct, 3,000 mg/day split TID may be appropriate (Vuksan protocol).

For CVT-E002 / Cold-fX: 200 mg twice daily as standard dose during infection season. Can be increased to 400 mg twice daily during acute symptoms (first 72 hours of cold/flu-like symptoms) for potential severity reduction.

At this stage, indication-specific customization:

Cancer-related fatigue: 2,000 mg/day Wisconsin Ginseng (Barton 2013 protocol) for 8-16 weeks. Split 1,000 mg with breakfast and 1,000 mg with lunch. Coordinate with oncologist regarding timing with chemotherapy cycles.
Chronic fatigue / post-viral fatigue: 1,000-2,000 mg/day for 8-12 weeks minimum. May combine with Asian ginseng 500 mg for dual-species approach if partial response.
T2DM adjunct (alongside diet and/or metformin): 3,000 mg/day split TID with meals for 12+ weeks. Monitor glucose closely.
Cognitive performance (acute or chronic): Single dose 200-400 mg Scholey-style 30-60 minutes before cognitive demand (exams, presentations, high-stakes work); or chronic 500-1,000 mg/day for sustained support.
Immune support during respiratory infection season: CVT-E002 200 mg twice daily continuously through winter (October-March in Northern Hemisphere) OR whole-root American ginseng 500-1,000 mg/day as alternative.
Hypertension with T2DM: 3,000 mg/day American ginseng + Vuksan-approved standardization for BP and glucose dual benefit over 12 weeks.
Post-exercise recovery (active adults): 500-1,500 mg/day with breakfast, plus 500 mg post-workout for enhanced recovery.

At this dose range, cycling is optional but commonly practiced. A 4-weeks-on / 1-week-off pattern is traditional, though no Western trial has compared cycling to continuous use. Continuous daily dosing for 6-12 months has been demonstrated safe.

Brand options:

Wisconsin Ginseng Board-certified: CW Ginseng, HSU's Ginseng, Burnett Ginseng
CVT-E002: Cold-fX (Canada), COLD-fX (US where available)
Life Extension American Ginseng
NOW American Ginseng
Gaia Herbs American Ginseng
Canadian Ontario ginseng: Peak Performance, various Ontario growers
Combination products (American + Asian ginseng): Ginseng America, various blends

Advanced

Advanced Protocol (experienced users, targeted indications):

Dose range 3,000-9,000 mg/day of American ginseng whole root powder, split TID with meals. This upper range is reserved for:

Severe T2DM or metabolic syndrome with inadequate response to lower doses (9 g/day Vuksan protocol)
Severe cancer-related fatigue unresponsive to 2,000 mg Barton protocol (titrate to 3-4 g/day under oncologist supervision)
Chronic fatigue syndrome or post-viral fatigue with incomplete response to 2,000 mg/day
Age-related vitality decline in elderly with titration based on response

For CVT-E002: advanced dosing rarely exceeds 200 mg three times daily (600 mg total); higher doses have not been well-studied and offer diminishing returns.

Advanced-level considerations:

Titration: From 2 g/day to 9 g/day over 4-6 weeks. Avoid abrupt dose increases.
Dual-species combination at high dose: For users not responding adequately to single-species high-dose American ginseng, adding Asian ginseng 500-1,500 mg/day provides complementary Rg1-dominant ginsenoside profile. This dual-species approach is traditional in Korean medicine (blending the two species for balanced effect) and is a reasonable advanced-user strategy.
Red/steamed American ginseng: Less commonly available than steamed Asian ginseng (Korean Red Ginseng), but some specialty producers offer "red American ginseng" with enhanced Rg3/Rh2 content from processing. This may be worth exploring for users seeking anti-inflammatory and anti-cancer emphasis.
Fermented/compound K preparations: Pre-fermented American ginseng (compound K-enriched) provides improved bioavailability and more predictable effects for users with disrupted gut microbiomes. Less commercially available than fermented Asian ginseng but emerging as a specialty product category.
Drug interaction management at high dose: At 6-9 g/day, drug interactions become clinically meaningful. Warfarin patients require close INR monitoring. Antidiabetic medication patients require close glucose monitoring with possible dose reductions. Transplant recipients should avoid entirely.
Quality matters more at high dose: At 6-9 g/day cumulative root intake, contamination with pesticides, heavy metals, or adulterants from non-Wisconsin/non-Ontario sources becomes proportionately more significant. Stick with Wisconsin Ginseng Board-certified or verified Canadian Ontario producers.
Cycling at high dose: After 3-6 months of continuous high-dose use, a 2-4 week break may be prudent to reassess response and allow for potential receptor recalibration. No trial has demonstrated need for cycling, but it's a reasonable conservative practice.
Discontinuation: Gradual taper over 1-2 weeks if cycling off extended high-dose use. Abrupt discontinuation does not produce withdrawal but may cause transient return of fatigue or cognitive symptoms within 2-4 weeks.

Compare advanced dosing in panax ginseng, rhodiola rosea, cordyceps, ashwagandha.

Commonly Stacked With

American ginseng stacks well with most cognitive, immune, metabolic, and adaptogen compounds. Its calming Rb1-dominant profile makes it particularly complementary to stimulating compounds (balancing overstimulation) and to immune-supporting compounds (additive effects).

The cancer-related fatigue stack (American ginseng + CoQ10 + omega-3 + creatine + vitamin D). Based on Barton 2013 evidence, the canonical CRF stack centers on Wisconsin Ginseng 2,000 mg/day as the primary intervention, supplemented by CoQ10 100-300 mg/day (mitochondrial support), omega-3 2,000-3,000 mg EPA+DHA (anti-inflammatory), creatine 3-5 g/day (cellular energy), and vitamin D to maintain 25-OH-D >40 ng/mL. This five-compound approach addresses the multi-mechanism nature of CRF: mitochondrial dysfunction (CoQ10, creatine), inflammation (omega-3, ginseng), muscle wasting (creatine, vitamin D), and generalized fatigue (ginseng). For cancer patients, coordinate with oncologist regarding timing with chemotherapy (some oncologists recommend avoiding antioxidants during active chemo).

The winter immune support stack (CVT-E002 + vitamin D + vitamin C + zinc + elderberry). For fall/winter respiratory infection prevention, particularly in elderly, immune-compromised, or high-exposure populations (healthcare workers, teachers, parents of young children), combine CVT-E002/Cold-fX 200 mg twice daily + vitamin D 2,000-5,000 IU/day + vitamin C 500-1,000 mg/day + zinc 15-30 mg/day + elderberry 500-1,000 mg during acute symptoms. CVT-E002 provides chronic immune priming via polysaccharide-mediated macrophage/NK cell activation; vitamins D, C, and zinc provide well-established immune cofactors; elderberry provides acute antiviral support during early symptoms. Begin in September-October and continue through March-April in Northern Hemisphere.

The type 2 diabetes adjunct stack (American ginseng + berberine + alpha-lipoic acid + chromium + magnesium). For T2DM or prediabetes adjunct to lifestyle and/or metformin, combine American ginseng 2-3 g/day + berberine 500 mg two or three times daily + alpha-lipoic acid 600-1,200 mg/day + chromium picolinate 200-400 mcg/day + magnesium glycinate 300-400 mg/day. Each compound targets different aspects of glucose metabolism: ginseng (insulin sensitization via compound K), berberine (AMPK activation, gut microbiome modulation), ALA (glucose uptake and antioxidant), chromium (insulin signaling cofactor), magnesium (insulin receptor sensitivity). Monitor glucose closely due to additive hypoglycemia risk with antidiabetic medications.

The stimulant-balance stack (Asian ginseng morning + American ginseng afternoon). For users who want ginseng's fatigue-reducing and immune-supporting benefits but find Asian ginseng overstimulating, split the day: Asian ginseng/KRG 500-1,000 mg with breakfast (morning energy, physical vitality) + American ginseng 500-1,000 mg with lunch (calm cognitive focus, anti-inflammatory support). This combination provides the full ginsenoside spectrum with balanced stimulant/calming effects throughout the day.

The cognitive performance stack (American ginseng + bacopa + lion's mane + citicoline + omega-3). For users wanting cognitive support without stimulant effects, American ginseng 200-400 mg acute or 500-1,000 mg chronic + bacopa monnieri 300 mg/day + lion's mane 1,000 mg/day + citicoline 250-500 mg/day + omega-3 2,000 mg/day. This five-compound approach provides acute cognitive performance (American ginseng, citicoline), chronic structural support (bacopa, lion's mane), and substrate support (omega-3). Particularly valuable for knowledge workers, students, and elderly users seeking cognitive maintenance without the insomnia or anxiety risks of stimulant-based stacks.

The post-exercise recovery stack (American ginseng + creatine + omega-3 + tart cherry). For athletes or active older adults seeking recovery support, American ginseng 1,000 mg post-workout + creatine 5 g/day + omega-3 3,000 mg/day + tart cherry 500-1,000 mg daily. American ginseng's anti-inflammatory and mitochondrial support contributes to recovery; creatine supports muscle ATP; omega-3 reduces inflammation; tart cherry reduces exercise-induced oxidative stress.

The chemotherapy supportive care stack (American ginseng + glutamine + ginger + probiotics). For cancer patients undergoing chemotherapy with GI side effects and fatigue, American ginseng 1-2 g/day + l-glutamine 5-10 g/day (mucositis prevention) + ginger 1-2 g/day (nausea) + probiotics multi-strain (gut microbiome support). Coordinate with oncologist — some oncologists are concerned about botanical interactions with specific chemotherapy agents.

Compounds to avoid stacking with American ginseng:

Prescription MAO inhibitors (contraindicated, though less concerning than with Asian ginseng)
High-dose immunosuppressants in transplant patients
Warfarin without INR monitoring

Compounds with neutral-to-complementary interaction:

Curcumin, resveratrol, pterostilbene — complementary anti-inflammatory and longevity
NAD+ precursors (NMN, NR) — complementary mitochondrial support
Rhodiola rosea — can be combined without pronounced additive stimulant effect
Ashwagandha — complementary calming adaptogen, safe to combine
Bacopa monnieri — complementary cognitive support

For comparison with related compound stacks, see panax ginseng, rhodiola rosea, ashwagandha, bacopa monnieri, and cordyceps.

Side Effects & Safety

American ginseng has one of the most favorable side-effect profiles among adaptogens and nootropic herbs. Its calming, Rb1-dominant profile produces fewer stimulant-like side effects than Asian ginseng, and the large clinical trial database (>5,000 subjects exposed) has not identified any serious toxicity at typical therapeutic doses. **Common side effects (2-5% of users at therapeutic doses):** - Mild GI upset, nausea, or loose stools (3-5%) — typically mild, transient, and reduced by taking with food. - Mild headache (2-4%) — often dehydration-related or early treatment, usually resolves within 1-2 weeks. - Occasional insomnia (1-3%) — much lower rate than Asian ginseng due to the calming Rb1-dominant profile, but still possible if dosed late in the day. Morning-only dosing prevents sleep disruption. - Mild hypoglycemia symptoms in diabetic patients (2-5%) — additive with antidiabetic medications, requires glucose monitoring when starting. - Slight BP changes (1-3%) — generally mild reductions rather than elevations (unlike Asian ginseng which can produce slight BP increases in some users). **Uncommon side effects (1-3%):** - Allergic skin reactions (rash, itching) — rare. - Dry mouth or slight taste changes — 1-2%. - Mild menstrual irregularities in women — 1-2%, reversible on discontinuation. - Mild palpitations or tachycardia — 1-2%, less common than with Asian ginseng. **Rare side effects (<1%):** - Significant hypoglycemia requiring intervention — rare and primarily in patients on antidiabetic medications. - Serious allergic reactions — rare, similar rates to other botanical products. - Hepatotoxicity — extremely rare, with isolated case reports. - Mania or hypomania — very rare, possibly in bipolar spectrum patients (less common than with Asian ginseng). **"Ginseng abuse syndrome" — the short version:** Siegel's 1979 report describing hypertension, diarrhea, nervousness, and insomnia in chronic ginseng users was based primarily on Asian ginseng at extreme doses (15+ g/day) and adulterated products. American ginseng at typical doses (1-3 g/day) does not produce this syndrome. Even at the higher doses used in some cancer fatigue trials (2 g/day Barton protocol) or T2DM trials (3-9 g/day Vuksan), serious adverse events have not been observed. **Drug interactions:** - Warfarin — case reports of altered INR with ginseng (both reduced and increased). Monitor INR closely when starting or stopping American ginseng. - MAO inhibitors — theoretical additive sympathetic effects, though American ginseng is less stimulating than Asian. Prudent to avoid combining. - Antidiabetic medications (insulin, sulfonylureas, metformin, GLP-1 agonists, SGLT2 inhibitors) — additive hypoglycemia risk. Monitor glucose closely when starting; reduce antidiabetic medication dose if significant hypoglycemia occurs. - PDE5 inhibitors — theoretical additive vasodilation but less pronounced than with Asian ginseng. Generally safe. - Antihypertensive medications — additive BP reduction. Monitor BP when starting. - Antiplatelet and anticoagulant drugs (warfarin, aspirin, clopidogrel, DOACs) — mild additive antiplatelet effect. Monitor for bleeding. - Immunosuppressants (post-transplant drugs, methotrexate, biologics) — theoretical opposition via American ginseng's immune-stimulating activity. Avoid in transplant patients. - Stimulant medications — modest additive effect, much less pronounced than with Asian ginseng. - Estrogen therapy — theoretical mild additive estrogenic effect from Rb1 phytoestrogen activity. **Populations requiring caution:** - Hormone-sensitive cancers (ER+ breast cancer, prostate cancer, ovarian cancer) — theoretical phytoestrogen concern (though American ginseng has weaker estrogenic activity than Asian), discuss with oncologist. - Active autoimmune disease (SLE, RA, MS, Hashimoto's, Graves', IBD, psoriasis) — theoretical immune activation concern. - Bipolar disorder — rare reports of mania induction (less common than with Asian ginseng). - Uncontrolled hypertension — generally safer than Asian ginseng but still monitor BP. - Bleeding disorders or upcoming surgery — discontinue 1-2 weeks before surgery. - Pregnancy — insufficient safety data, avoid. - Breastfeeding — insufficient safety data, avoid. - Children under 18 — insufficient pediatric safety data for healthy children. - Organ transplant recipients — avoid entirely. **Contraindicated populations:** - Prescription MAO inhibitors - Active bleeding or coagulopathy - Within 2 weeks of scheduled surgery - Transplant recipients on immunosuppression - Active mania or psychotic depression - Known severe hypersensitivity **Discontinuation:** American ginseng does not produce physical dependence, tolerance, or withdrawal syndrome. Stop abruptly when no longer needed. Cognitive and fatigue benefits fade over 1-3 weeks post-discontinuation. Compare to the side-effect profiles of [panax ginseng](/compound/panax-ginseng), [rhodiola rosea](/compound/rhodiola-rosea), [ashwagandha](/compound/ashwagandha), [bacopa monnieri](/compound/bacopa-monnieri), and [cordyceps](/compound/cordyceps).

Contraindications

**Absolute contraindications (do not use):** - Prescription MAO inhibitors — additive sympathetic effect risk (less pronounced than Asian ginseng but still prudent to avoid) - Active bleeding or severe coagulopathy - Within 2 weeks of scheduled major surgery (mild antiplatelet activity) - Transplant recipients on immunosuppression (immune stimulation could trigger rejection) - Active mania or psychotic depression - Known severe hypersensitivity to Panax species or related Araliaceae plants - Pregnancy — insufficient safety data, avoid - Breastfeeding — insufficient safety data, avoid **Relative contraindications (use with caution):** - Warfarin therapy — monitor INR closely - Antidiabetic medications (insulin, sulfonylureas, metformin, GLP-1 agonists) — additive hypoglycemia, monitor glucose - Hormone-sensitive cancers (ER+ breast cancer, prostate cancer) — weaker phytoestrogen activity than Asian ginseng but theoretical concern remains; discuss with oncologist - Active autoimmune disease (SLE, RA, MS, Hashimoto's, Graves', IBD) — theoretical immune activation concern - Bipolar disorder — rare reports of mania (less common than with Asian ginseng) - Bleeding disorders — mild antiplatelet activity - Children under 18 — insufficient pediatric safety data - Uncontrolled hypertension — generally neutral or slightly hypotensive but monitor - Hyperthyroidism — theoretical sympathetic concern (less than Asian ginseng) **Populations requiring clinician oversight:** - Pregnancy and lactation (avoid) - Active cancer treatment — coordinate with oncologist (the Barton 2013 CRF evidence supports use but some oncologists prefer avoiding antioxidants during chemo) - Diabetes on multiple medications (hypoglycemia risk) - Elderly on polypharmacy (drug interaction risk) - Organ transplant recipients (avoid) **Pharmacological red flags during use:** - Unexpected hypoglycemia in diabetic patients — reduce ginseng or antidiabetic medication dose - New-onset insomnia — switch to morning-only dosing, reduce dose if persists - Significant BP changes (>15 mmHg) — evaluate and adjust - Unexplained bleeding or bruising — discontinue, evaluate - Allergic symptoms — discontinue immediately - Mania, hypomania, or psychotic symptoms — immediate discontinuation **Legal status:** American ginseng (Panax quinquefolius) is protected under CITES Appendix II, requiring permits for international trade. Wild harvest is federally regulated in the US, with licenses required for commercial harvest in states where it's native. Cultivated American ginseng is widely available as a dietary supplement (DSHEA-regulated in the US), a natural health product (Health Canada NPN-regulated in Canada), and a traditional medicine in various jurisdictions. CVT-E002 / Cold-fX is OTC in Canada under natural health product regulation. WADA does not prohibit American ginseng in competitive sport.

Check interactions with the Interaction Checker →

Additional Notes

American ginseng dosing is best anchored to whole-root gram equivalents for most indications, with standardized extracts (CVT-E002 200 mg = approximately 1-2 g whole root equivalent for immune indications) providing alternative dosing strategies for specific applications. Therapeutic dose range across the literature is 500 mg to 9,000 mg/day whole root.

Evidence-based doses by indication:

Cancer-related fatigue (Barton 2013): 2,000 mg/day Wisconsin Ginseng whole root for 8+ weeks
Respiratory infection prevention (McElhaney 2004): CVT-E002 200 mg twice daily over winter season
Type 2 diabetes adjunct (Vuksan): 3,000-9,000 mg/day whole root split TID
Cognitive performance (Scholey 2010): 200 mg acute single dose, 500-1,000 mg/day chronic
General vitality / immune support: 1,000-2,000 mg/day

Timing: Morning dose with breakfast is the standard. American ginseng is less stimulating than Asian ginseng, so afternoon dosing is usually tolerated, but morning-only dosing remains the safer default for sleep-sensitive users. For CVT-E002, morning and evening dosing (12 hours apart) is used in the McElhaney protocol.

With food: Take with food (particularly a meal containing some fat) to improve tolerability and potentially enhance absorption of ginsenosides. Empty-stomach dosing is generally tolerated but may cause mild GI upset in 3-5% of users.

Chronic versus cycled use: Both are valid. Continuous daily use for 6-12 months has been demonstrated safe. Traditional Chinese medicine often recommends cycling (4-weeks-on / 1-week-off, or 3-months-on / 1-month-off) based on philosophical rather than scientific grounds. For indications like T2DM or CRF, continuous use is appropriate. For seasonal indications (winter immune support), seasonal use is appropriate.

Dose-response considerations: The Vuksan T2DM trials showed clear dose-response up to 9 g/day for glucose effects. The Barton CRF trial used 2 g/day and this represents the evidence-based dose for cancer-related fatigue. The CVT-E002 immune trials used 400 mg/day (200 mg BID) consistently. For cognitive and general vitality indications, effects plateau at 1-3 g/day for most users. Higher doses are reserved for severe or refractory indications.

Extract standardization conversions:

1 g Wisconsin Ginseng whole root ≈ 200-300 mg of 4-5% standardized extract (depending on root ginsenoside content, typically higher than Asian ginseng due to higher Rb1)
CVT-E002 200 mg ≈ approximately 1-2 g whole root equivalent (polysaccharide content basis)
Compound K-enriched extract 100-200 mg/day ≈ 1-2 g whole root equivalent (bioavailability basis)

Forms and preparations:

Whole root (sliced or powdered): traditional form, can be chewed raw (fresh root), encapsulated, or brewed as tea
Capsules: convenient, ranges from 250 mg to 1,000 mg per capsule
Liquid extract (alcoholic tincture): 2-5 mL TID typical
CVT-E002 / Cold-fX: 200 mg capsules, specific polysaccharide-enriched extract
Tea from dried root: 3-6 g dried root simmered 30-60 minutes in 500 mL water
Fresh root: available in some Asian markets and specialty shops; can be sliced and chewed or brewed fresh

Wisconsin Ginseng Board-certified sources: CW Ginseng (Marathon County, Wisconsin), HSU's Ginseng (Wausau, Wisconsin), Burnett Ginseng (Marathon County), Wausau Paper Ginseng (Marathon County), Trinity Farms Wisconsin Ginseng. The Ginseng Board of Wisconsin certifies quality and authenticity; look for their certification mark.

Canadian Ontario sources: Ontario Ginseng Growers Association-certified producers. Similar quality tier to Wisconsin Board-certified, distinct terroir and slightly different ginsenoside profile.

Avoid:

Unverified "American ginseng" without Wisconsin or Canadian certification
Products mixing American and Asian ginseng without clear labeling
Products with vague "Panax species" labeling
Bulk powders from non-verified sources
Extracts without standardization specification

Frequently Asked Questions

What is the recommended American Ginseng dosage?

Dosage for American Ginseng varies by protocol. Consult a qualified healthcare provider.

How often should I take American Ginseng?

Administration frequency depends on the specific protocol. Consult current research literature.

Does American Ginseng need to be cycled?

Cycling requirements depend on the protocol. Follow established research guidelines.

What are American Ginseng side effects?

Where can I buy American Ginseng?

Visit our vendor directory to find trusted sources for American Ginseng.

American Ginseng Full Profile

Research data, mechanisms, and pricing

Interaction Checker

Check drug & compound interactions

Free 2026 Peptide Cheat Sheet — 50 pages, PDF

Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.

Download Free